![](/img/cover-not-exists.png)
The dual peroxisome proliferator–activated receptor α/γ agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin
Serena Tonstad, Kjetil Retterstøl, Leiv Ose, K. Peter Öhman, Magnus B. Lindberg, Maria SvenssonVolume:
56
Year:
2007
Language:
english
DOI:
10.1016/j.metabol.2007.05.003
File:
PDF, 345 KB
english, 2007